Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion type Assertion NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_head.
- NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_provenance.
- NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion evidence source_evidence_literature NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_provenance.
- NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion SIO_000772 17962208 NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_provenance.
- NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion wasDerivedFrom befree-2016 NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_provenance.
- NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion wasGeneratedBy ECO_0000203 NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_provenance.